Oxford University Innovation

Caristo Diagnostics Limited, based in Oxford, United Kingdom, specializes in artificial intelligence-driven software for cardiovascular diagnostics. Founded in 2018, the company focuses on improving heart health assessments through its advanced imaging technology. By developing tools that analyze Cardiac Computed Tomography Angiography (CCTA), Caristo enables the measurement of Fat Attenuation Index (FAI) during routine heart check-ups. This innovative approach enhances the diagnostic accuracy of coronary angiograms, allowing healthcare professionals to identify inflammation in the coronary arteries and predict risks of heart attacks, strokes, and diabetes. Through its proprietary technology, Caristo Diagnostics aims to support medical professionals in making informed treatment decisions to better manage cardiovascular health.

Brill Power Ltd. is a clean-tech company based in Oxford, United Kingdom, specializing in energy storage solutions using lithium-ion battery cells. Founded in 2016, the company focuses on developing advanced battery management technology that enhances the performance and longevity of battery packs. Its innovative control concepts and software are designed to significantly improve the efficiency and cost-effectiveness of battery systems, catering to applications in stationary energy storage and electric vehicles. Brill Power aims to provide sustainable energy solutions that benefit communities and contribute to a greener society.

OMass Technologies Ltd engages in drug discovery by applying mass spectrometry to the characterization of intact protein assemblies. The company offers biotherapeutics, membrane proteins, drug binding, and purifications guiding services. In addition, OMass Technologies Ltd offers structural mass spectrometry (MS) platforms, often referred to as native mass spectrometry, for characterizing complex protein assemblies. The company assists biotechnology and pharmaceutical companies in tackling drug targets and biotherapeutics. OMass Technologies Ltd was founded in 2016 and is based in Begbroke, United Kingdom.

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

PepGen is a clinical-stage biotechnology company based in Oxford, United Kingdom, focused on advancing the delivery of nucleic acid therapeutics, particularly antisense oligonucleotides. Established in 2018, PepGen aims to enhance the clinical efficacy of these therapeutics through its proprietary Enhanced Delivery Oligonucleotide (EDO) platform. This innovative technology employs engineered peptides designed for optimized tissue penetration, cellular uptake, and nuclear delivery, enabling effective transport of oligonucleotides to various target tissues, including smooth, skeletal, and cardiac muscle, as well as the central nervous system. By leveraging its drug delivery capabilities, PepGen seeks to transform the treatment landscape for severe neuromuscular and neurological diseases.

PepGen is a clinical-stage biotechnology company based in Oxford, United Kingdom, focused on advancing the delivery of nucleic acid therapeutics, particularly antisense oligonucleotides. Established in 2018, PepGen aims to enhance the clinical efficacy of these therapeutics through its proprietary Enhanced Delivery Oligonucleotide (EDO) platform. This innovative technology employs engineered peptides designed for optimized tissue penetration, cellular uptake, and nuclear delivery, enabling effective transport of oligonucleotides to various target tissues, including smooth, skeletal, and cardiac muscle, as well as the central nervous system. By leveraging its drug delivery capabilities, PepGen seeks to transform the treatment landscape for severe neuromuscular and neurological diseases.

Refeyn specializes in label-free single molecule imaging and mass measurement, offering advanced microscopy solutions for detecting and quantifying molecules. Their technology enables users to perform precise imaging, localization, and accurate mass determination of individual biomolecules in solution. This innovative approach serves various sectors, particularly pharmaceutical, biomedical, and research industries. Founded in 2018 and headquartered in Oxford, United Kingdom, Refeyn aims to enhance research capabilities by providing tools that facilitate a deeper understanding of molecular interactions and properties.

Oxford Flow Ltd. specializes in the design, manufacture, and supply of pressure control equipment, including gas regulators, water pressure reducing valves, silencers, and pilots. Established in 2015 and headquartered in Oxford, United Kingdom, the company serves a diverse range of industries such as water, gas, marine, oil and gas, process, power, and building services. Oxford Flow combines expertise from academia and industry to create practical solutions that enhance operational efficiency while minimizing environmental impact. Each of their products is developed through rigorous testing and customer feedback, ensuring reliability and performance in challenging conditions.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Perspectum Diagnostics Ltd. is a medical technology company based in Oxford, United Kingdom, with additional offices in Singapore and the United States. Founded in 2012, it specializes in developing innovative technologies for diagnosing and measuring liver diseases through advanced magnetic resonance imaging. The company's flagship product, LiverMultiScan, provides objective and quantitative assessments of liver health, aiding in the detection and measurement of liver, gallbladder, and pancreatic diseases, including precancerous and cancerous conditions. Perspectum's technologies are also utilized in clinical trials to evaluate investigational therapies for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. By focusing on precision medicine, Perspectum aims to enhance patient care through early detection, accurate diagnosis, and targeted treatment, leveraging a diverse team of experts in medicine and technology. As of March 2020, the company operates as a subsidiary of Ambra Health, Inc.

Oxford VR Limited, founded in 2016 and based in Oxford, United Kingdom, specializes in developing automated cognitive treatments for various clinical conditions, including fear of heights, psychosis, and social anxiety. Originating from research at Oxford University by Professor Daniel Freeman, the company harnesses immersive virtual reality technology to deliver therapy through a virtual coach. This innovative approach aims to significantly increase access to mental health treatments, making them faster, more effective, and lower in cost compared to traditional methods. Oxford VR focuses on creating clinically validated and user-centered therapies that not only benefit patients but also positively impact the healthcare system and the broader economy.

Oxford Semantic Technologies develop RDFox, the first market-ready high-performance knowledge graph designed from ground up with semantic reasoning in mind. Oxford Semantic Technologies was founded in 2017 as a spin-out of the University of Oxford with a mission to bring cutting-edge research in semantic web technologies to industry. The team started working on RDFox in 2011 at the Computer Science Department of the University of Oxford with the conviction that flexible and high-performance reasoning was a possibility for data extensive applications without jeopardising the correctness of the results. Patented modern computing techniques underpin RDFox’s ability to deliver responses to complex queries on the fly. This has unlocked a new wave of enterprise applications for prestigious partners.

Oxford VR Limited, founded in 2016 and based in Oxford, United Kingdom, specializes in developing automated cognitive treatments for various clinical conditions, including fear of heights, psychosis, and social anxiety. Originating from research at Oxford University by Professor Daniel Freeman, the company harnesses immersive virtual reality technology to deliver therapy through a virtual coach. This innovative approach aims to significantly increase access to mental health treatments, making them faster, more effective, and lower in cost compared to traditional methods. Oxford VR focuses on creating clinically validated and user-centered therapies that not only benefit patients but also positively impact the healthcare system and the broader economy.

Evox Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing exosome-based therapeutics for the treatment of severe diseases. Founded in 2016, the company leverages its proprietary technology to harness and engineer extracellular vesicles, known as exosomes, for the targeted delivery of nucleic acids and proteins. This innovative approach aims to enhance drug delivery to challenging areas, such as the brain and central nervous system, where conventional therapies often fall short. Evox’s mission is to improve human health by creating novel therapeutics that address significant medical needs, particularly for conditions with limited treatment options. The company has built a comprehensive intellectual property portfolio and is backed by prominent life sciences venture capital groups, positioning it as a leader in the emerging field of exosome-based drug delivery.

Refeyn specializes in label-free single molecule imaging and mass measurement, offering advanced microscopy solutions for detecting and quantifying molecules. Their technology enables users to perform precise imaging, localization, and accurate mass determination of individual biomolecules in solution. This innovative approach serves various sectors, particularly pharmaceutical, biomedical, and research industries. Founded in 2018 and headquartered in Oxford, United Kingdom, Refeyn aims to enhance research capabilities by providing tools that facilitate a deeper understanding of molecular interactions and properties.

BibliU is a digital educational service designed to enhance the learning experience for university students. It provides access to a vast library of textbooks and monographs, allowing students to search for relevant materials easily. The platform also facilitates interaction among students and professors, promoting collaborative learning and engagement. By streamlining access to educational content, BibliU aims to make the learning process more efficient and effective.

Orbit Discovery Ltd. is a peptide display technology company based in Oxford, United Kingdom, founded in 2015. The company specializes in identifying peptide drugs aimed at treating chronic diseases by leveraging its innovative in vitro display technology. This technology utilizes small beads to connect randomized peptide sequences with their corresponding DNA, facilitating the screening of peptides for various disease types. Orbit Discovery focuses on developing a screening platform that identifies potential peptide drug candidates for both internal drug discovery programs and collaborative research initiatives. The company’s platform offers a means to discover and optimize novel, biologically relevant peptides, capitalizing on the unique properties of peptides that combine the specificity and efficacy of larger biologic molecules with the advantages of smaller molecules, such as reduced dosing and simpler manufacturing processes. This approach aims to enhance the discovery and development of peptide-based therapeutics.

Oxford Flow Ltd. specializes in the design, manufacture, and supply of pressure control equipment, including gas regulators, water pressure reducing valves, silencers, and pilots. Established in 2015 and headquartered in Oxford, United Kingdom, the company serves a diverse range of industries such as water, gas, marine, oil and gas, process, power, and building services. Oxford Flow combines expertise from academia and industry to create practical solutions that enhance operational efficiency while minimizing environmental impact. Each of their products is developed through rigorous testing and customer feedback, ensuring reliability and performance in challenging conditions.

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Oxford Biotrans Limited is a company based in Abingdon, United Kingdom, specializing in the development, production, and commercialization of high-value chemical compounds through innovative enzyme technology. Founded in 2013, the company utilizes patented cytochrome P450 enzyme technology, which is backed by over 15 years of research from Dr. Luet Lok Wong of the University of Oxford. Its flagship product is Nootkatone, a natural grapefruit flavor and scent derived from the biotransformation of Valencene, a citrus extract. Oxford Biotrans is focused on bringing to market a range of flavors and fragrances, while also exploring applications of its technology in the production of pheromones, pharmaceuticals, and other specialty chemicals.

Diffblue is changing the way software is developed using Artificial Intelligence (AI). Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification and synthesis, and customers include Goldman Sachs and Amazon Web Services. Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK.

Scenic Biotech B.V., founded in 2017 and based in Amsterdam, specializes in developing genomics and immunotherapy technologies aimed at addressing cancer and rare genetic diseases at their genetic roots. The company focuses on identifying disease-suppressing genes that serve as "off-switches" for GPCR signaling, enabling innovative therapeutic interventions. Scenic Biotech's approach involves unlocking genetic modifiers that can suppress or block the effects of disease-causing mutated genes. This technology allows for the rapid identification and validation of novel drug targets, facilitating the development of disease-modifying therapeutics that aim to improve the lives of patients suffering from severe conditions.

Climate change is one of the biggest threats today. PowerMarket, supported by the University of Oxford and European Space Agency Business Incubator, is on a mission to facilitate sustainable energy for all, creating energy independence. The traditional energy model is based on centralised, large-scale electricity generation systems. The model is not only capital intensive, but also has high carbon emissions. To combat the threat of climate change, countries are increasingly switching to renewable electricity. However, at a national scale, most still focus on large-scale energy generation plants that require heavy capital investment. Sustainable energy transition challenge is not only for governments and public sector institutions, but for all of us. PowerMarket’s objective is to help individuals and companies to cost effectively install decentralised renewable energy generation and battery storage, so that they can become increasingly energy independent and protect themselves from rising energy prices. First few steps towards an energy revolution - PowerMarket’s pilot Satellite Assessment Tool (SAT) allows individuals and companies to assess their property’s solar feasibility within a few clicks, and for free. Now you can use this information to find suppliers, finance and maintenance solutions fit for your need.

Bodle Technologies Limited provides advanced optoelectronic solutions for displays and smart windows. It offers zero-power reflective displays that are bi-stable reflective displays with ultra-high resolution; smart windows; and security coatings that change color under mechanical, optical or electrical probing techniques that result in unbreakable security features in currencies, ID cards, and official documentation. Its reflective displays are used in wearables, near-eye, and projection based displays. Bodle Technologies Limited was incorporated in 2015 and is headquartered in Begbroke, United Kingdom.

Fuel3D is a company that specializes in affordable handheld 3D scanning technology, aimed at providing high-quality 3D shape and color capture for various creative applications. The Fuel3D scanner is a point-and-shoot device that utilizes pre-calibrated stereo cameras combined with photometric imaging to quickly capture high-resolution mesh and color information of objects. This innovative approach addresses the common challenges of time and cost associated with generating quality 3D images, which often exceed $15,000 for traditional scanners, making them inaccessible for many independent developers and artists. Originally developed at Oxford University for medical imaging, Fuel3D's technology is now being adapted for the broader 3D market, with the intention of making point-and-shoot 3D imaging accessible to both consumers and professionals. The company is led by Stuart Mead, who brings extensive experience from various successful technology ventures.

Fungry is an online food application dedicated to enhancing the quality of takeaway food in Oxford by connecting customers with local independent restaurants. The platform simplifies the process of discovering exceptional cuisine by featuring a curated selection of dishes crafted by local chefs. Fungry emphasizes the importance of supporting local businesses while ensuring that customers enjoy a diverse range of high-quality food options. By streamlining the search for great local dining, Fungry aims to provide a convenient and satisfying takeaway experience for its users.

Covatic Ltd, established in 2016 and headquartered in Birmingham, United Kingdom, specializes in broadcast personalization software. The company utilizes mobile-based algorithms to enhance user experiences through smart personalization in applications. With an additional office in London, Covatic aims to refine its technology and expand its offerings, focusing on developing innovative solutions that meet the needs of its users. The team is composed of dedicated problem solvers committed to advancing their products and fostering partnerships with like-minded individuals and organizations.

Cycle.land Limited operates an online bicycle sharing platform based in Oxford, United Kingdom, with additional offices in Cambridge and Edinburgh. Founded in 2016, the company connects bike owners with individuals seeking bicycles, facilitating rentals during times when the owners are not using their bikes. The platform serves colleges, businesses, and institutions, allowing users to find, share, and book bicycles from local cyclists and vendors. This service promotes a vibrant community of cycling enthusiasts, fostering connections among students, residents, and visitors. By enabling easy access to bicycles, Cycle.land not only supports sustainable transportation but also encourages social interaction within the cycling community.

Redacto represents a totally new approach to online language learning. Using authentic recordings of people from different walks of life, as well as news broadcasts and vox pops, Redacto provides English language learners of all levels with intensive and relevant listening practice. Users are supported by hints, score feedback, variable audio speed and Google’s speech to text technology. Students can invite a friend to compete against online. Both users can collaborate in real time as they see each other’s correctly guessed words populate their screens, along with scores and feedback. Learning is consolidated by post listening vocabulary exercises.

Cycle.land Limited operates an online bicycle sharing platform based in Oxford, United Kingdom, with additional offices in Cambridge and Edinburgh. Founded in 2016, the company connects bike owners with individuals seeking bicycles, facilitating rentals during times when the owners are not using their bikes. The platform serves colleges, businesses, and institutions, allowing users to find, share, and book bicycles from local cyclists and vendors. This service promotes a vibrant community of cycling enthusiasts, fostering connections among students, residents, and visitors. By enabling easy access to bicycles, Cycle.land not only supports sustainable transportation but also encourages social interaction within the cycling community.

Bodle Technologies Limited provides advanced optoelectronic solutions for displays and smart windows. It offers zero-power reflective displays that are bi-stable reflective displays with ultra-high resolution; smart windows; and security coatings that change color under mechanical, optical or electrical probing techniques that result in unbreakable security features in currencies, ID cards, and official documentation. Its reflective displays are used in wearables, near-eye, and projection based displays. Bodle Technologies Limited was incorporated in 2015 and is headquartered in Begbroke, United Kingdom.

Xerion Healthcare Limited is a UK-based company focused on developing and commercializing nanoparticle treatments to enhance the effectiveness of cancer therapies, specifically targeting head, neck, and pancreatic tumors. Founded in 2015, the company utilizes titanium dioxide nanoparticles, a non-toxic semiconductor material, which are injected into tumors prior to standard radiotherapy. This innovative approach amplifies the dose of free radicals produced by X-rays, thereby improving the treatment's efficacy while minimizing potential side effects. By integrating this nanomedicine technology into conventional radiotherapy, Xerion Healthcare aims to provide more effective solutions for patients with challenging cancer types.

Gyana was founded in 2015 by Oxford University students. Currently a global startup headquartered in London-this award winning team is deeply passionate about using the power of NOCODE to unleash the potential of the AI revolution to everyone.

Wrapidity Limited is a London-based company that specializes in web data extraction, transforming unstructured web content into structured data formats. Established in 2015 and operating as a subsidiary of Meltwater News US Inc., Wrapidity employs artificial intelligence to automate the data extraction process. This technology eliminates the need for manual web scraping, which can be time-consuming and costly, by allowing users to provide a small sample of the desired data. The AI then determines the appropriate websites to crawl, how to interact with their content, and the best methods for continuous data extraction. This innovation benefits a range of users, including businesses, policymakers, and scientists, by enabling them to efficiently collect and analyze relevant data from the web without the overhead of traditional engineering resources.

Total Mama is a digital health company focused on supporting women throughout various stages of motherhood, including pre-pregnancy, pregnancy, and postpartum. The company utilizes AI-based technology to deliver personalized, evidence-based health information tailored to individual health profiles and demographic data. By aligning this information with national clinical guidelines and other reputable sources, Total Mama aims to provide women with reliable maternal and reproductive health resources. The platform facilitates access to valuable guidance and insights from third-party content providers, empowering women to make informed decisions regarding their health and well-being during critical periods of their lives.

Genomics PLC is focused on advancing the use of genomic data to transform healthcare. The company develops algorithms and software solutions that facilitate the analysis of large genomic and phenotypic datasets, aimed at understanding human biology and improving disease diagnosis and treatment. Its offerings serve a diverse range of clients, including governments, healthcare providers, pharmaceutical companies, and research laboratories. By providing tools that enhance the accuracy of genetic analysis, Genomics PLC helps de-risk the drug development process and enables clinicians to better identify individuals at risk for specific diseases. Founded in 2014 and based in Oxford, United Kingdom, the company aims to set standards in genomic data application, ultimately benefiting organizations and patients alike through innovative healthcare solutions.

Oxbotica is developing the next generation of autonomous vehicles - creating the software that makes them go. Using the latest in computer vision and machine learning, their systems learn from their environment and share experiences with each other, so that they're getting smarter all the time. The system uses a complement of sensors and algorithms to identify and track pedestrians, cars and other obstacles in the environment.

Oxford BioChronometrics, founded in 2014, specializes in developing cyber security software aimed at combating digital fraud. Originating from technology at the Oxford University Innovation center, the company offers a suite of products designed to enhance the integrity of online advertising and secure web interactions. Their Digital Media Solutions quantify fraud, particularly from non-human sources, enabling advertisers to verify and optimize their traffic sources. The SecureAd Suite provides measurable insights into ad performance across various platforms, ensuring that advertisers only pay for legitimate engagement. Additionally, their Cyber Solutions focus on preventing fraud before it occurs, using continuous credential validation to ensure only human users access services. Key products include Secure Form, a tool to mitigate spam, SecureLeads for verifying genuine form submissions, and Secure Checkout, which prevents fraudulent credit card entries. The company has gained recognition for its innovative approach, including winning the NATO 2017 Defense Innovation Challenge, and continues to expand its offerings with upcoming products like their Fake News solution.

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company based in Abingdon, United Kingdom, specializing in innovative cell therapies for cancer treatment, particularly targeting solid tumors. The company utilizes its specific peptide enhanced affinity receptor (SPEAR) T-cell platform to identify and genetically engineer T-cell receptors that enhance the immune response against cancerous cells. Current clinical trials are exploring various therapeutic candidates, including ADP-A2M4 for multiple solid tumor types and ADP-A2AFP for hepatocellular carcinoma. Adaptimmune has formed strategic collaborations with several organizations, including GSK for the development of NY-ESO T-cell therapy and Noile-Immune Biotech Inc. for combining SPEAR T-cells with PRIME technology. Founded in 2008, Adaptimmune is committed to advancing T-cell therapies to improve patient outcomes in oncology and beyond.

Oxitec is a biotechnology company focused on developing environmentally friendly solutions for controlling insect pests that transmit diseases and damage crops. Founded in 2002 and based in Oxford, United Kingdom, the company utilizes proprietary technology derived from research at the University of Oxford. This technology enhances the traditional Sterile Insect Technique (SIT) by integrating genetics and molecular biology, making it more cost-effective and safe for a wider range of insect pests. Oxitec offers various genetically modified strains, including Aedes aegypti and Aedes albopictus, which target disease-carrying mosquitoes, as well as strains for agricultural pests like the Diamondback moth and Pink bollworm. These innovations aim to provide targeted, non-toxic, and scalable pest control solutions that protect public health, agricultural productivity, and ecosystems. The company also operates a mosquito production facility in Piracicaba, Brazil, contributing to its global efforts in pest management.

OxSyBio Ltd. specializes in developing advanced 3D printing techniques to create tissue-like and functional tissues for medical research and clinical applications. The company focuses on producing innovative materials made up of three-dimensional networks of lipid monolayer aqueous droplets. These materials can conduct electrical signals along designated pathways and have the ability to self-fold into complex geometries. This technology has potential applications in regenerative medicine, including organ repair and replacement, aiming to enhance precision medicine. Founded in 2014 and based in London, OxSyBio draws upon cutting-edge research from Professor Hagan Bayley's group at the University of Oxford, known for its expertise in chemical and synthetic biology.

Designer Carbon Materials Ltd specializes in the development of advanced nanomaterials, focusing on endohedral metallofullerenes for various applications such as energy harvesting, bio-sensing, and quantum nanoelectronics. The company emerged as a spin-out from the University of Oxford, building on over 12 years of research led by Dr. Kyriakos Porfyrakis and his team. They have successfully synthesized and chemically functionalized endohedral fullerenes, creating materials with tailored electronic properties. This innovative approach allows clients to utilize a range of nanostructures, including nanotubes and their derivatives, in both scientific and industrial applications.

Singular Intelligence Limited specializes in developing an artificial intelligence platform for brands and retailers, focusing on the consumer packaged goods, food and drink, beauty, and home care sectors. The platform enhances commercial decision-making by automating processes related to pricing, promotions, marketing mix modeling, and supply planning, while also facilitating retail, e-commerce, and direct-to-consumer automation. Founded in 2013 and headquartered in London, the company leverages advanced analytics, AI, and big data to provide accurate insights that support businesses in real-time decision-making. Singular Intelligence emphasizes the importance of integrating various market factors to optimize marketing strategies and improve performance indicators. The company's innovative offerings include SiDAX™, a dynamic insight solution that utilizes visual analytics and smart data to empower organizations to make timely decisions based on a diverse array of data.

Genomics PLC is focused on advancing the use of genomic data to transform healthcare. The company develops algorithms and software solutions that facilitate the analysis of large genomic and phenotypic datasets, aimed at understanding human biology and improving disease diagnosis and treatment. Its offerings serve a diverse range of clients, including governments, healthcare providers, pharmaceutical companies, and research laboratories. By providing tools that enhance the accuracy of genetic analysis, Genomics PLC helps de-risk the drug development process and enables clinicians to better identify individuals at risk for specific diseases. Founded in 2014 and based in Oxford, United Kingdom, the company aims to set standards in genomic data application, ultimately benefiting organizations and patients alike through innovative healthcare solutions.

OxCEPT has developed a cross-platform, front-end, mobile application and a back-end server system that provides an extra layer of security for transmitting data. The patents and IP surrounding this proprietary technology allow information to be transmitted securely between any and all devices. Extra Security. Extra Peace Of Mind.

Chronos Therapeutics’ drug development scheme focuses in two main areas: - Repositioning FDA approved drugs. - Screening, discovery and development of novel proprietary drug candidates. Current Targets - Diseases of Ageing: Osteoporosis, Cancer and Sarcopenia. - Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, ALS and Orphan Synucleopathies. Chronos Therapeutics’ research is successfully advancing from pre-clinical stages of development for age-related disease treatments to clinical development. Chronos' pioneering drug discovery and development platform the Chronoscreen has enabled the company to quickly gain proprietary positions in the regulation of cellular chronological lifespan. Some of the most exciting and effective therapeutic approaches of the future will utilize our understanding of the biological programming of life-span and ageing that take place in every cell of our body. Harnessing this knowledge will lead to novel treatments for age related diseases such as Alzheimer's Disease, Diabetes, Cancer and Osteoporosis.

Oxford MEStar specializing in translational and regenerative medicine. We devote ourselves to a) developing novel technologies; b) offering bioengineering solutions to our clients; and c) technology transfer between the UK and China.

vDabble delivers learning and playtime activities for kids in the ages 3-7 years right to their doors with all supplies.

Perspectum Diagnostics Ltd. is a medical technology company based in Oxford, United Kingdom, with additional offices in Singapore and the United States. Founded in 2012, it specializes in developing innovative technologies for diagnosing and measuring liver diseases through advanced magnetic resonance imaging. The company's flagship product, LiverMultiScan, provides objective and quantitative assessments of liver health, aiding in the detection and measurement of liver, gallbladder, and pancreatic diseases, including precancerous and cancerous conditions. Perspectum's technologies are also utilized in clinical trials to evaluate investigational therapies for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. By focusing on precision medicine, Perspectum aims to enhance patient care through early detection, accurate diagnosis, and targeted treatment, leveraging a diverse team of experts in medicine and technology. As of March 2020, the company operates as a subsidiary of Ambra Health, Inc.

Starticles is an online platform that allows individuals to showcase their knowledge and ideas by sharing content such as research and insights. Users can present their work to the Starticles community, which provides ratings and feedback on the submissions. This interactive process enables users to earn recognition and points based on the quality of their contributions. As users gain recognition for their content, they enhance their profiles, thereby increasing their career opportunities. The platform focuses on valuing the quality of ideas over traditional qualifications, fostering a community that encourages knowledge sharing and expertise.

OxLegal was created to solve the problems of lawyers, it’s are a software venture which enable firms to leverage on technology in their workflow processes. Lawyers can complete tasks in a fraction of the time, reducing costs and allowing them to focus on higher value strategic work. Reputation is protected through risk mitigation.

Oxpert specializes in providing online business software designed to assist micro businesses, particularly tradespeople like gas engineers and electricians, in enhancing their web presence and managing their operations. The company offers tools that enable these small enterprises to grow and effectively compete against larger competitors by streamlining brand management and operational processes. Through its services, Oxpert aims to empower tradespeople to establish a stronger foothold in the market and improve their overall business performance.

Edspire is an online learning platform that serves as a search engine for educational resources, utilizing advanced algorithms to classify a wide range of content including MOOCs, videos, OpenCourseWare, tutorials, and screencasts. In response to the rapid expansion of online educational resources, Edspire aims to facilitate users in navigating the diverse array of learning materials available, which disrupts traditional educational methods. The platform recognizes the increasing trend of individuals seeking customized learning experiences through various providers, rather than relying solely on conventional institutions. By providing a context for these diverse resources, Edspire helps users identify materials that best support their formal studies and professional development. The company is incubated by the Isis software incubator, part of Isis Innovation at the University of Oxford.

TipTapped is a sports data provider. We analyse social media to find out what people are saying about upcoming sports games. TipTapped aggregate the data to show outcome forecasts for upcoming games, along with the complete prediction histories for each individual.We then share this data with sports fans, sports media and other sports companies.

Oxford Vacmedix was established in 2012 as a spinout from Oxford University. Its aim is to develop therapeutic agents for the treatment of cancer based on the invention of Dr Shisong Jiang - Recombinant Overlapping Peptides (ROP). These agents are an exciting new way to deliver immunotherapy which is now a major focus in the treatment of cancer, making it easier to deliver, more effective and much more economical. Immunotherapy is effective by activating the immune system to attack tumours directly thus reducing the need for invasive treatments such as chemo and radiotherapy.

goKomplain lets you to voice your discontent and allows the public to offer solutions.

SmartEatOut is a group dining solution bringing together people and restaurants. By signing up for free people can join Smart-groups and meet others around the table or simply book a table for a private celebration with their friends.

Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, specializing in non-contact vital signs monitoring solutions for various sectors, including healthcare, fitness, automotive, and security. Founded in 2012, Oxehealth has developed the Oxecam software, which utilizes a digital video camera to remotely measure vital signs such as heart rate, respiratory rate, and blood oxygenation without physical contact. This innovative technology is particularly beneficial for monitoring elderly and vulnerable individuals in settings where staff presence may be limited. Oxehealth's Digital Care Assistant generates alerts regarding risky activities and provides objective data on patient activity and vital signs, enhancing care planning and allowing caregivers to focus on hands-on support. The company has achieved a world-first certification for its software as a medical device, demonstrating its commitment to transforming care environments. Oxehealth's proprietary algorithms leverage deep learning and computer vision to deliver accurate monitoring, making it a valuable tool in mental health, prison, and acute care settings.

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Onfido Limited is a provider of identity verification solutions that utilizes artificial intelligence to authenticate users' identities through the analysis of government-issued IDs and facial biometrics. Established in 2010 and headquartered in London, the company has expanded its presence globally with offices in several major cities, including San Francisco and New Delhi. Onfido's technology is designed to streamline the identity verification process across various sectors, including financial services, e-commerce, and transportation, helping clients onboard users while minimizing risk. The platform enables businesses to verify identities securely and efficiently, supporting applications in areas such as KYC, fraud detection, and user onboarding. With a client base of over 1,500 organizations, Onfido is positioned to transform how identity verification is approached, facilitating seamless access to services ranging from banking to travel.

MeVitae operates an online recruitment platform designed to enhance diversity and inclusivity in hiring processes for organizations. The platform utilizes data-driven technology to assist businesses in attracting, screening, and retaining top talent while ensuring a fair approach to building diverse and productive teams. By integrating seamlessly with existing applicant tracking systems (ATS) and customer relationship management (CRM) tools, MeVitae allows companies to maintain their current processes without disruption. The solution emphasizes the importance of personalized hiring that aligns with a company's culture, all while eliminating algorithmic and neurological biases. This enables clients to achieve a more transparent and efficient automated talent acquisition process.

Award winning digital health platform called "Fuell" with a goal of getting Employees to achieve weekly health goals. Data Collection from wearables Engagement through self service and sponsored challenges Loyalty and Monetisation through tokens Low cost monthly subscription with data driven outcomes for Employers, Brands and Organisations.

WhatsOnCampus connects students to activities happening on and around their campus.

Oxford Imaging Detectors develops high performance scientific imaging detectors capable of studying structures and processes at the atomic level.

Esplorio is a digital travel diary platform that allows users to record their journeys and share their experiences with others. The service enables individuals to document their travels in an organized manner, making it easy to reminisce about past adventures and share memories with friends and family. Additionally, Esplorio provides tools for discovering new destinations, enriching the travel experience by helping users find interesting places to explore. Through its user-friendly interface, Esplorio aims to enhance the way travelers capture and share their journeys.

Oxford Geo-Social Technologies – OXGEOS™ was founded in March 2012, in Oxford, United Kingdom. OXGEOS has a core team of Oxford Graduates who are motivated by a world of possibilities for geo-social technology.OXGEOS provides world class platforms for social games, social communities and geo-social advertising technologies.

Pilio is a scientifically robust energy-management software. Through the employment of advanced weather analysis algorithms and energy efficiency benchmarking, we can accurately calculate and track your savings. Intuitive, easy-to-access dashboards and reports, designed by building energy experts, are delivered straight to your inbox or via our online platform, empowering you to make lasting financial, energy and carbon savings across your estate.

colwiz (collective wizdom) is a free research management, collaboration and productivity platform for individual researchers, groups, departments and organizations. Utilizing web, desktop (Windows, Mac , Linux) and mobile applications synced in real time, the platform manages the entire research lifecycle from an initial idea, through a complex collaboration, to publication of the results. colwiz The company was founded by leading researchers from the University of Oxford.

IXO Therapeutics Ltd. is a biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.

Kepler Energy Limited is a UK-based development stage company founded in 2010, focused on the development and manufacturing of innovative tidal turbines designed to harness tidal energy. The company holds an exclusive license for a patented second-generation tidal turbine, originally developed by academics at the University of Oxford. Kepler's turbines are distinct in their larger, scalable design and capability to operate effectively in low tidal stream velocities, which are common in coastal waters worldwide. This technology allows for the construction of tidal fences, optimizing energy production and providing incremental revenue during the construction phase. Kepler Energy aims to address gaps in the tidal energy market by offering a cost-effective and powerful solution for sustainable energy generation, positioning itself as a leader in this emerging sector without direct economic competitors in specific resource areas.

Navetas Energy Management Ltd. is an energy management company based in Woodbridge, United Kingdom, established in 2008. It specializes in cloud-based energy monitoring and smart data analytics for connected homes, offering solutions that include the Loop platform for monitoring electricity and gas consumption. The Loop platform provides real-time analytics and automated tariff advice, enabling users to track their energy usage and explore various energy tariffs daily through a secure web interface. Additionally, the company provides the Navetas Zeo Smart Hub, which serves as a communications gateway for various metering services, and the Navetas Zeo Smart Gas Meter that utilizes precision fibre optics for gas meter communication. Navetas markets its services directly to consumers on a subscription basis and through online retailers, aiming to enhance energy measurement, procurement, and conservation across residential and commercial sectors.

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).